BCTXZ · BriaCell Therapeutics Corp.
$0.14
+0.01 (+10.66%)
At close · Oct 27
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jun 9, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, the Company's ability to continue as a going concern is dependent upon its ability to attain future profitable operations and to continue to obtain the necessary financing to meet its obligations arising from normal business operations when they come due. The uncertainty of the Company's ability to raise such financial capital casts substantial doubt on the Company's ability to continue as a going concern.”View the 10-Q filed Jun 9, 2026
Market Cap
$30.97M
Shares
8.70M
Volume · Oct 27
10.29K
Avg daily vol (3M)
59.81K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.14
Open$0.14
Day$0.13–0.15
Available close range$0.09–0.30
Avg vol 30d16K
Last earningsOct 28, 2022
DataJul 2026–Oct 2026
Filing10-Q · Jun 9
The closing range uses available history since Jul 23, 2026; less than a full year is stored.
Up next
filed Jun 9, 2026
Technicals
trend & momentum for long-term holders illustrative — not investment adviceMarket signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
2 of 27 funds reported for Sep 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
No short-interest data
Volume signal
Normal
Volume near normal
Institution breadth
Steady
27 holders — mid 3-yr range
Price context
position in its available closing range
Range low $0
Now $0 · 23%
Range high $0
vs 50-day avg -19%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BCTXZ
this stock
BriaCell Therapeutics Corp.
|
$30.97M | — | — | — | — |
|
VRTX
Vertex Pharmaceuticals Inc
|
$131.20B | +14.9% | +46.2% | 30.2 | 1.7% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$83.15B | +5.7% | +20.8% | 20.0 | 2.1% |
|
MRNA
Moderna, Inc.
|
$79.39B | +605.2% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$66.49B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Holders
27
- % held
- 47.1%
- Reported
- 2 of 27
- Top holder
- CITADEL ADVISORS LLC
Held
Float
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BCTXZ | -16.0% | -26.5% | — | -31.8% | — |
| SPY | +0.1% | +0.7% | +4.9% | +0.9% | +12.9% |
| vs SPY | -16.1% | -27.2% | — | -32.7% | — |